Pharma

The Future of FemTech: A Deep Dive into Women’s Health and Pharma’s Expanding Role

In a recent webinar titled “The Future of FemTech,” hosted by Reuters Events Pharma, industry leaders got together to explore the ever evolving landscape and intersection of women’s health technology also known as FemTech and the pharma industry. The session, moderated by Femtech Insider’s Kathrin Folkendt, featured an expert panel comprising Elcie Chan from Otsuka, Fatima Perez Sastre from Novartis, Paula Antunes…

Bayer’s Elinzanetant Shows Promise in Alleviating Vasomotor Symptoms Associated with Menopause

Bayer has announced positive topline results from the Phase III OASIS 3 study, shedding light on the potential efficacy and safety of their investigational compound, elinzanetant, in treating moderate to severe vasomotor symptoms (VMS) linked to menopause. These findings bolster the case for elinzanetant’s marketing authorization submissions, which Bayer plans to present to health authorities. In the OASIS 3 study, elinzanetant demonstrated…

Roche Simplifies PCOS Diagnosis with New CE-Marked Blood Test

Roche Diagnostics has recently received CE-mark regulatory approval for a novel method of diagnosing Polycystic Ovary Syndrome (PCOS), a common endocrine disorder affecting approximately 1 in 8 women of reproductive age. The newly approved Elecsys Anti-Müllerian Hormone (AMH) Plus immunoassay, previously used in fertility diagnostics, now offers a non-invasive alternative to the traditional transvaginal ultrasound for diagnosing PCOS. PCOS, characterized by a…

Organon Launches Bacterial Vaginosis Treatment XACIATO in the US

Organon, a global healthcare company focusing on women’s health, announced US-wide availability of XACIATO (clindamycin phosphate) vaginal gel 2% by prescription for the treatment of bacterial vaginosis (BV) in females aged 12 and older. BV, a condition resulting from an overgrowth of certain bacteria, disrupts the natural vaginal microbiome, leading to symptoms like odor and discharge. It affects approximately 21 million women…

Daré Bioscience Receives Grant from Gates Foundation to Develop Biotherapeutic Products for Infant and Women’s Health

Daré Bioscience, a women’s health company, has announced the receipt of a $750K grant from the Bill & Melinda Gates Foundation. This funding is earmarked for the development of bacteria-based live biotherapeutic products, aiming to enhance the health of women and newborns globally. This recent grant follows a previous award of approximately $585K from the foundation, granted to Daré in November 2022…

Asieris Pharmaceuticals Establishes Women’s Health Business Unit to Advance Gynecological Care

Asieris Pharmaceuticals has launched a new Women’s Health Business Unit, focusing on advancing treatments in gynecology, particularly for cervical cancer. The initiative centers on APL-1702, a non-surgical treatment for cervical high-grade squamous intraepithelial lesions, positioning the company at the forefront of innovative gynecological care. This move aligns with global health initiatives aimed at combating cervical cancer. The China National Program for Women’s…

Daré Bioscience Advances DARE-LARC1 Drug Delivery Platform for Women’s Health

Daré Bioscience, a biopharma company specializing in women’s health, has announced the development of DARE-LARC1, a drug delivery platform that can administer therapeutic doses over extended periods. This platform is designed to store and precisely deliver medications for months or years through a single device. The technology behind DARE-LARC1, developed initially at the Massachusetts Institute of Technology by Drs. Robert Langer and…

Pearsanta Acquires MDNA’s Mitomic Platform for Endometriosis and Ovarian Cancer Detection for $25M

Pearsanta, a subsidiary of Aditxt, has recently acquired the Mitomic testing platform from MDNA Life Sciences. The transaction, valued at approximately $25 million, is a strategic expansion for Pearsanta, enhancing its capabilities in early disease and cancer detection, particularly in women’s health, focusing on conditions such as endometriosis and ovarian cancer. The Mitomic technology utilizes mitochondrial DNA (mtDNA) to detect diseases at…